Profiling the Endocannabinoid Response to Hedonic Eating
Lekkere trek
1 other identifier
interventional
25
0 countries
N/A
Brief Summary
Study into the endocannabinoid response to consuming a palatable versus a neutral food.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Sep 2015
Shorter than P25 for not_applicable obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2015
CompletedFirst Submitted
Initial submission to the registry
April 9, 2017
CompletedFirst Posted
Study publicly available on registry
April 13, 2017
CompletedMay 24, 2017
May 1, 2017
23 days
April 9, 2017
May 22, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Endocannainoid levels
To assess changes in endocannabinoid plasma levels prior to, during and after eating a palatable versus a neutral food
prior to, during and two hours after eating
Secondary Outcomes (2)
Pancreatic polypeptide (pg/ml)
prior to, during and two hours after eating
Ghrelin (pg/ml)
prior to, during and two hours after eating
Study Arms (2)
Palatable-neutral
EXPERIMENTALParticipants are exposed to palatable food in the first test session, and to the neutral food in the second test session.
Neutral-palatable
EXPERIMENTALParticipants are exposed to neutral food in the first test session, and to the palatable food in the second test session.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy (self-report)
- Dutch
- Evaluating one of the used foods as palatable
- Evaluating one of the used foods as neutral
- Hb value between 8.1 and 11.0 mmol/L at screening
You may not qualify if:
- restraint eating
- lack of appetite
- difficulties eating/swallowing
- endocrine disorders
- energy restricted diet two months prior to study
- weight change \> 5 kg in two months prior to study
- stomach or bowel disease
- taste or smell disorders (self-report)
- not consuming foods used in the study
- smoking \> 1 cigarette per day
- drinking \> 21 units alcohol per week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2017
First Posted
April 13, 2017
Study Start
September 15, 2015
Primary Completion
October 8, 2015
Study Completion
October 8, 2015
Last Updated
May 24, 2017
Record last verified: 2017-05